MolecularMD Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MolecularMD Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0129
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging strategies, clinical trial design, regulatory planning, analytical and clinical assay validation, fda submission services, and custom clinical gmp kit manufacturing. Its technologies comprise next generation sequencing, droplet digital pcr, qpcr, rt-qpcr, allele-specific pcr, sanger sequencing, capillary electrophoresis fragment analysis, immunohistochemistry, hematoxylin and eosin staining, and digital imaging. MMD’s clinical trails services include centralized clinical testing, clinical trial assay and IVD development, advanced diagnostics, and manufacturing commercialization. The company serves the biopharma’s needs for clinical trial assays and clinical trial services. It operates offices in Oregon and Massachusetts, the US. MMD is headquartered in Portland, Oregon, the US.

MolecularMD Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MolecularMD Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MolecularMD Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
MolecularMD Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MolecularMD Corp, Medical Equipment, Deal Details 11
Venture Financing 11
MolecularMD Raises USD0.5 Million in Venture Financing 11
MolecularMD Raises US$2.5 Million In Venture Financing 12
MolecularMD Raises US$6 Million In Series B Financing 13
Partnerships 14
MolecularMD Enters Into Licensing Agreement With Broad Institute And Dana-Farber Cancer Institute 14
MolecularMD Enters Into Licensing Agreement With Washington University And Translational Genomics Research Institute 15
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 16
MolecularMD and Genoptix Enter into Agreement 18
MolecularMD Enters into Agreement with Indica Labs 19
Asterand Bioscience Enters into Partnership with MolecularMD 20
MolecularMD Enters into Agreement with Illumina 21
Definiens Partners with MolecularMD 22
MolecularMD Enters Into Agreement With Novartis To Develop Companion Diagnostic Test For Chronic Myelogenous Leukemia 23
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 24
MolecularMD Corp – Key Competitors 25
MolecularMD Corp – Key Employees 26
MolecularMD Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Legal and Regulatory 28
Jun 01, 2017: MolecularMD achieves status as an ArcherDX Certified Service Provider and expands offering of novel NGS chemistries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
MolecularMD Corp, Medical Equipment, Key Facts 2
MolecularMD Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MolecularMD Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MolecularMD Corp, Deals By Market, 2012 to YTD 2018 8
MolecularMD Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
MolecularMD Raises USD0.5 Million in Venture Financing 11
MolecularMD Raises US$2.5 Million In Venture Financing 12
MolecularMD Raises US$6 Million In Series B Financing 13
MolecularMD Enters Into Licensing Agreement With Broad Institute And Dana-Farber Cancer Institute 14
MolecularMD Enters Into Licensing Agreement With Washington University And Translational Genomics Research Institute 15
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 16
MolecularMD and Genoptix Enter into Agreement 18
MolecularMD Enters into Agreement with Indica Labs 19
Asterand Bioscience Enters into Partnership with MolecularMD 20
MolecularMD Enters into Agreement with Illumina 21
Definiens Partners with MolecularMD 22
MolecularMD Enters Into Agreement With Novartis To Develop Companion Diagnostic Test For Chronic Myelogenous Leukemia 23
Personal Genome Diagnostics And MolecularMD Enter Into Agreement For Genomic Testing Services 24
MolecularMD Corp, Key Competitors 25
MolecularMD Corp, Key Employees 26
MolecularMD Corp, Other Locations 27

List of Figures
MolecularMD Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MolecularMD Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
MolecularMD Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
MolecularMD Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
MolecularMD Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[MolecularMD Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NantKwest Inc (NK):企業の財務・戦略的SWOT分析
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Verde Science Inc-石油・ガス分野:企業M&A・提携分析
    Summary Verde Science Inc (Verde Science), formerly Rango Energy Inc is a medical technology company that offers bioprocess solutions. The company offers research and development services with expertise in bioprocess technology, molecular virology and immunology, nanotechnology, pharmacology and med …
  • Swallowfield PLC:企業の戦略・SWOT・財務情報
    Swallowfield PLC - Strategy, SWOT and Corporate Finance Report Summary Swallowfield PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sanyo Chemical Industries Ltd (4471):企業の財務・戦略的SWOT分析
    Sanyo Chemical Industries Ltd (4471) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Security Devices International Inc.:企業の戦略・SWOT・財務情報
    Security Devices International Inc. - Strategy, SWOT and Corporate Finance Report Summary Security Devices International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • The Brookwood Partnership Ltd:企業の戦略・SWOT・財務分析
    The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report Summary The Brookwood Partnership Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Biomerica Inc (BMRA):企業の財務・戦略的SWOT分析
    Biomerica Inc (BMRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • Polydex Pharmaceuticals Ltd (POLXF):企業の財務・戦略的SWOT分析
    Summary Polydex Pharmaceuticals Ltd (PPL) is a manufacturer and marketer of pharmaceutical intermediates for human and veterinary pharmaceutical markets. The company manufactures and sells bulk quantities of dextran and derivative products. Its dextran and its derivatives can be used as adjuvants, e …
  • SATT South East SAS-製薬・医療分野:企業M&A・提携分析
    Summary SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology c …
  • Allscripts Healthcare Solutions Inc (MDRX)-医療機器分野:企業M&A・提携分析
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management solutions, Population Health Manag …
  • 3-V Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 3-V Biosciences Inc (3-V Biosciences) is a clinical-stage pharmaceutical company that develops novel therapeutics in metabolic diseases. The company offers TVB-2640, a fatty acid synthase inhibitor used for the treatment of solid tumors, including non-small cell lung cancer (NSCLC), breast c …
  • H.I.S. Co., Ltd.:戦略・SWOT・企業財務分析
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CureMeta LLC-製薬・医療分野:企業M&A・提携分析
    Summary CureMeta LLC (CureMeta) is a biotechnology company that concentrates on the development of immunology therapeutics for cancers. The company advances novel antibody drug conjugates targeting pluripotent stem cells. Its pipeline product comprises Bstrongximab-ADC. CureMeta develops the antibod …
  • ELITechGroup Inc:医療機器:M&Aディール及び事業提携情報
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry produ …
  • WebMD Health Corp:企業の戦略的SWOT分析
    WebMD Health Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Fluidigm Corp (FLDM):企業の財務・戦略的SWOT分析
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • Dana Petroleum Ltd:企業の戦略的SWOT分析
    Dana Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • China Medical System Holdings Ltd (867):製薬・医療:M&Aディール及び事業提携情報
    Summary China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆